Prodrugs comprising an GLP-1/glucagon dual agonist linker hyaluronic acid conjugate Grant US-10806797-B2 United States of America 20 Oct 2020
Exendin-4 derivatives as dual GLP1/glucagon agonists Grant US-10758592-B2 United States of America 01 Sep 2020
Exendin-4 derivatives as selective peptidic dual GLP-1/glucagon receptor agonists Grant US-9982029-B2 United States of America 29 May 2018
Exendin-4 derivatives as selective glucagon receptor agonists Grant US-9932381-B2 United States of America 03 Apr 2018
Exendin-4 peptide analogues as dual GLP-1/GIP receptor agonists Grant US-9789165-B2 United States of America 17 Oct 2017
Exendin-4 derivatives as peptidic dual GLP-1/glucagon receptor agonists Grant US-9775904-B2 United States of America 03 Oct 2017
Peptidic dual GLP-1/glucagon receptor agonists derived from exendin-4 Grant US-9771406-B2 United States of America 26 Sep 2017
Dual GLP-1/glucagon receptor agonists derived from exendin-4 Grant US-9758561-B2 United States of America 12 Sep 2017
Dual GLP1/GIP or trigonal GLP1/GIP/glucagon agonists Grant US-9745360-B2 United States of America 29 Aug 2017
NEW EXENDIN-4 DERIVATIVES AS SELECTIVE PEPTIDIC DUAL GLP-1 / GLUCAGON RECEPTOR AGONISTS Application WO-2017009236-A3 World Intellectual Property Organisation (WIPO) 16 Feb 2017
EXENDIN-4 DERIVATIVES AS DUAL GLP-1 /GLUCAGON RECEPTOR AGONISTS Application WO-2016198604-A1 World Intellectual Property Organisation (WIPO) 15 Dec 2016
NON-ACYLATED EXENDIN-4 DERIVATIVES AS DUAL GLP-1/GLUCAGON RECEPTOR AGONISTS Application WO-2016198628-A1 World Intellectual Property Organisation (WIPO) 15 Dec 2016